Driving groundbreaking insights at the single-cell level, millions of times
Mass cytometry, powered by CyTOF® technology, is the world’s most advanced cytometric platform. It has opened new doors to discovery and clinical research by empowering investigators to interrogate more than 50 markers simultaneously on millions of individual cells. Join the hundreds who have reimagined cytometry with CyTOF to unveil new cell types, functions and biomarkers in immunology, cancer, infectious disease and more.
TRENDING NOW PUBLICATIONS TOPICS
Explore these compilations of recent mass cytometry publications focused on specific areas of investigation.
December 2023 | NEW
Vaccine development and efficacy testing.
CyTOF for Drug Development
CyTOF for CAR Therapy
Maxpar Direct Immune Profiling Assay
COVID-19 research update
CAR T cells
The value of high-parameter cytometry
Cancer vaccine development
Vaccines for infectious disease
COVID-19 disease research